CRMD
Price
$7.69
Change
+$0.34 (+4.63%)
Updated
Feb 6 closing price
Capitalization
605.89M
50 days until earnings call
Intraday BUY SELL Signals
HOWL
Price
$0.61
Change
-$0.00 (-0.00%)
Updated
Feb 6 closing price
Capitalization
29.62M
39 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRMD vs HOWL

Header iconCRMD vs HOWL Comparison
Open Charts CRMD vs HOWLBanner chart's image
CorMedix
Price$7.69
Change+$0.34 (+4.63%)
Volume$1.57M
Capitalization605.89M
Werewolf Therapeutics
Price$0.61
Change-$0.00 (-0.00%)
Volume$205.28K
Capitalization29.62M
CRMD vs HOWL Comparison Chart in %
CRMD
Daily Signal:
Gain/Loss:
HOWL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRMD vs. HOWL commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMD is a Hold and HOWL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (CRMD: $7.69 vs. HOWL: $0.61)
Brand notoriety: CRMD and HOWL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRMD: 47% vs. HOWL: 31%
Market capitalization -- CRMD: $604.71M vs. HOWL: $29.62M
CRMD [@Biotechnology] is valued at $604.71M. HOWL’s [@Biotechnology] market capitalization is $29.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRMD’s FA Score shows that 1 FA rating(s) are green whileHOWL’s FA Score has 0 green FA rating(s).

  • CRMD’s FA Score: 1 green, 4 red.
  • HOWL’s FA Score: 0 green, 5 red.
According to our system of comparison, CRMD is a better buy in the long-term than HOWL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRMD’s TA Score shows that 5 TA indicator(s) are bullish while HOWL’s TA Score has 4 bullish TA indicator(s).

  • CRMD’s TA Score: 5 bullish, 5 bearish.
  • HOWL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CRMD and HOWL are a good buy in the short-term.

Price Growth

CRMD (@Biotechnology) experienced а -0.90% price change this week, while HOWL (@Biotechnology) price change was -7.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

CRMD is expected to report earnings on Mar 31, 2026.

HOWL is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRMD($606M) has a higher market cap than HOWL($29.6M). HOWL YTD gains are higher at: -3.362 vs. CRMD (-33.878). CRMD has higher annual earnings (EBITDA): 112M vs. HOWL (-65.99M). HOWL has more cash in the bank: 65.7M vs. CRMD (55.7M). HOWL has less debt than CRMD: HOWL (37.3M) vs CRMD (149M). CRMD has higher revenues than HOWL: CRMD (214M) vs HOWL (0).
CRMDHOWLCRMD / HOWL
Capitalization606M29.6M2,047%
EBITDA112M-65.99M-170%
Gain YTD-33.878-3.3621,008%
P/E Ratio3.47N/A-
Revenue214M0-
Total Cash55.7M65.7M85%
Total Debt149M37.3M399%
FUNDAMENTALS RATINGS
CRMD: Fundamental Ratings
CRMD
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
15
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRMDHOWL
RSI
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRMD
Daily Signal:
Gain/Loss:
HOWL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KGDZX36.640.91
+2.55%
DWS Global Small Cap R6
ACFSX75.361.48
+2.00%
American Century Focused Dynamic Gr I
SHSAX65.431.15
+1.79%
BlackRock Health Sciences Opps Inv A
FIQPX73.571.19
+1.64%
Fidelity Advisor Emerging Asia Z
NEQCX12.850.01
+0.08%
Neuberger U.S. Equity Impact C

CRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with HOTH. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then HOTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRMD
1D Price
Change %
CRMD100%
+4.63%
HOTH - CRMD
40%
Loosely correlated
+4.95%
MURA - CRMD
38%
Loosely correlated
N/A
CNSP - CRMD
37%
Loosely correlated
-0.88%
HOWL - CRMD
37%
Loosely correlated
+1.02%
BCAB - CRMD
36%
Loosely correlated
+10.78%
More

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been closely correlated with ARTV. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if HOWL jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
+1.02%
ARTV - HOWL
75%
Closely correlated
+4.13%
VTGN - HOWL
74%
Closely correlated
+11.52%
RZLT - HOWL
73%
Closely correlated
+6.85%
TPST - HOWL
72%
Closely correlated
+7.62%
MREO - HOWL
71%
Closely correlated
+13.20%
More